Market Tracker

09/22 5:16pm ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

2.12
Delayed Data
As of 3:59pm ET
 -0.165 / -7.22%
Today’s Change
1.65
Today|||52-Week Range
5.70
+21.84%
Year-to-Date

Today’s Trading

Previous close2.29
Today’s open2.30
Day’s range2.01 - 2.31
Volume193,680
Average volume (3 months)72,792
Market cap$35.3M
Dividend yield--
Data as of 3:59pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)+67.69%
Earnings growth (this year)-457.44%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+37.82%
P/E ratioNM
Price/Sales0.75
Price/Book0.59

Competitors

 Today’s
change
Today’s
% change
NTRPNeurotrope Inc+0.10+1.73%
PPHMPPeregrine Pharmaceut...-0.03-0.15%
PULMPulmatrix Inc-0.03-1.47%
PRPHProPhase Labs Inc+0.02+0.89%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 3, 2017
EPS forecast (this quarter)-$2.13
Annual revenue (last year)$33.7M
Annual profit (last year)-$24.5M
Net profit margin-72.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
Chief Operating Officer &
Executive Vice President
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts